Abstract
The ability of a hyperimmune Lew anti-BN serum (HIS) to induce enhancement of (Lew/BN)F1 kidneys transplanted into Lew recipients was compared to that of the same antiserum that had been depleted of hemagglutinating anti-Ag-B antibodies by absorption with Brown-Norway (BN) RBC-absorbed sera (RAS) or platelet-absorbed sera (PAS). The RAS and PAS were as effective as the unabsorbed HIS in abrogating early rejection as assessed by renal function and promotion of long-term survival. The absorbed sera retained the capacity to block the mixed lymphocyte culture (MLC) between Lew and BN lymphocytes and to a lesser degree the MLC between Lew and BUF, WF, AUG, and ACI lymphocytes; however, strain specificity was clearly evident at high antiserum dilutions. Similarly, these absorbed sera retained the capacity to block the Fc receptor of BN lymphocytes, and this effect was completely strain specific. In contrast, hemagglutinating and cytotoxic antibodies eluted from platelets used for antiserum absorption did not react with Fc receptors as assessed by rabbit antisheep (IgG)-coated SRBC (EA) rosette formation. F(Ab')2 fragments of PAS also blocked EA rosettes. On the other hand, complement rosettes (EAC) were not inhibited by the HIS. The antibodies were therefore directed against the Fc receptor itself or a structure spatially or functionally closely related to it. Both the Fc receptors and the enhancing capacity of the antisera were strictly specific for the BN genotype. It is suggested that the anti- "Fc receptor" antibody could play an important role in the induction of enhancement by impairing host T-B collaboration as a result of its binding to graft allogeneic "Fc receptors" which appear to be analogous to the major histocompatibility complex (MHC)-coded Ia antigens of the mouse.
Full Text
The Full Text of this article is available as a PDF (1.3 MB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Abbas A. K., Corson J. M., Carpenter C. B., Galvanek E. G., Merrill J. P., Dammin G. J. Immunologic enhancement of rat renal allografts. I. Comparative morphology of acutely rejecting and passively enhanced grafts. Am J Pathol. 1974 May;75(2):255–270. [PMC free article] [PubMed] [Google Scholar]
- Armerding D., Sachs D. H., Katz D. H. Activation of T and B lymphocytes in vitro. III. Presence of Ia determinants on allogeneic effect factor. J Exp Med. 1974 Dec 1;140(6):1717–1722. doi: 10.1084/jem.140.6.1717. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Burgos H., French M. E., Batchelor J. R. Humoral and cell-mediated immunity in rats with enhanced kidney allografts. Transplantation. 1974 Oct;18(4):328–335. doi: 10.1097/00007890-197410000-00005. [DOI] [PubMed] [Google Scholar]
- Davies D. A., Alkins B. J. What abrogates heart transplant rejection in immunological enhancement? Nature. 1974 Feb 1;247(5439):294–296. doi: 10.1038/247294a0. [DOI] [PubMed] [Google Scholar]
- Dickler H. B., Sachs D. H. Evidence for identity or close association of the Fc receptor of B lymphocytes and alloantigens determined by the Ir region of the H-2 complex. J Exp Med. 1974 Sep 1;140(3):779–796. doi: 10.1084/jem.140.3.779. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fabre J. W., Morris P. J. Experience with passive enhancement of renal allografts in A (DA x Lewis)F 1 to Lewis Strain combination. Transplantation. 1972 Jun;13(6):604–609. doi: 10.1097/00007890-197206000-00009. [DOI] [PubMed] [Google Scholar]
- Fabre J. W., Morris P. J. Passive enhancement of rat renal allografts with only partial cover of the incompatible Ag-B specificities. Transplantation. 1974 Nov;18(5):436–442. doi: 10.1097/00007890-197411000-00008. [DOI] [PubMed] [Google Scholar]
- French M. E., Batchelor J. R. Enhancement of renal allografts in rats and man. Transplant Rev. 1972;13:115–141. doi: 10.1111/j.1600-065x.1972.tb00062.x. [DOI] [PubMed] [Google Scholar]
- Guttmann R. D., Lindquist R. R., Ockner S. A. Renal transplantation in the inbred rat. IX. Hematopoietic origin of an immunogenic stimulus of rejection. Transplantation. 1969 Oct;8(4):472–484. doi: 10.1097/00007890-196910000-00019. [DOI] [PubMed] [Google Scholar]
- JACKSON J. F. Supravital blood studies, using acridine orange fluorescence. Blood. 1961 May;17:643–649. [PubMed] [Google Scholar]
- Jansen J. L., Koene R. A., Kamp G. J., Gerlag P. G., Wijdeveld P. A. Ehancement and hyperacute rejection of skin grafts in the mousefailure to separate cytotoxic and enhancing antibodies from alloantiserum with physicochemical methods. J Immunol. 1975 May;114(5):1557–1562. [PubMed] [Google Scholar]
- Lucas Z. J., Markley J., Travis M. Immunologic enhancement of renal allografts in the rat. I. Dissociation of graft survival and antibody response. Fed Proc. 1970 Nov-Dec;29(6):2041–2047. [PubMed] [Google Scholar]
- MOLLER G. Studies on the mechanism of immunological enhancement of tumor homografts. I. Specificity of immunological enhancement. J Natl Cancer Inst. 1963 Jun;30:1153–1175. [PubMed] [Google Scholar]
- McKearn T. J., Stuart F. P., Fitch F. W. Anti-idiotypic antibody in rat transplantation immunity. I. Production of anti-idiotypic antibody in animals repeatedly immunized with alloantigens. J Immunol. 1974 Dec;113(6):1876–1882. [PubMed] [Google Scholar]
- Roitt I. M., Greaves M. F., Torrigiani G., Brostoff J., Playfair J. H. The cellular basis of immunological responses. A synthesis of some current views. Lancet. 1969 Aug 16;2(7616):367–371. doi: 10.1016/s0140-6736(69)92712-3. [DOI] [PubMed] [Google Scholar]
- Rubinstein P., Decary F., Streun E. W. Quantitative studies on tumor enhancement in mice. I. Enhancement of sarcoma I induced by IgM, IgG1, and IgG2. J Exp Med. 1974 Aug 1;140(2):591–596. doi: 10.1084/jem.140.2.591. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sachs D. H., Cone J. L. Ir-associated murine alloantigens: demonstration of multiple Ia specificities in H-2 alloantisera after selective absorptions. J Immunol. 1975 Jan;114(1 Pt 1):165–169. [PubMed] [Google Scholar]
- Schirrmacher V., Halloran P., David C. S. Interactions of Fc receptors with antibodies against Ia antigens and other cell surface components. J Exp Med. 1975 May 1;141(5):1201–1209. doi: 10.1084/jem.141.5.1201. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Severson C. D., Thompson J. S. Quantitative semi-micro hemagglutination. A sensitive assay dependent upon cellular dissociation and migration in capillary tubes. J Immunol. 1966 May;96(5):785–789. [PubMed] [Google Scholar]
- Shreffler D. C., David C. S. The H-2 major histocompatibility complex and the I immune response region: genetic variation, function, and organization. Adv Immunol. 1975;20:125–195. doi: 10.1016/s0065-2776(08)60208-4. [DOI] [PubMed] [Google Scholar]
- Soulillou J. P., Carpenter C. B., Lundin A. P., Strom T. B. Augmentation of proliferation and in vitro production of cytotoxic cells by 2-ME in the rat. J Immunol. 1975 Dec;115(6):1566–1571. [PubMed] [Google Scholar]
- Staines N. A., Guy K., Davies D. A. Passive enhancement of mouse skin allografts. Specificity of the antiserum for major histocompatibility. Transplantation. 1974 Aug;18(2):192–195. [PubMed] [Google Scholar]
- Strom T. B., Carpenter C. B., Garovoy M. R., Abbas A. K., Corson J. M., Bear R. A., Soulillou J. P. Modification of the rat alloimmune response by enhancing antibodies and the role of blocking factors in the survival of renal grafts. Transplantation. 1975 Nov;20(5):368–380. doi: 10.1097/00007890-197511000-00003. [DOI] [PubMed] [Google Scholar]
- Stuart F. P., McKearn T. J., Fitch F. W. Immunological enhancement of renal allografts. Transplant Proc. 1974 Dec;6(4 Suppl 1):53–58. [PubMed] [Google Scholar]
- Zincke H., Woods J. E. Attempted immunological alteration of canine renal allograft donors. Transplantation. 1974 Dec;18(6):480–486. doi: 10.1097/00007890-197412000-00002. [DOI] [PubMed] [Google Scholar]